• In May 2026, Maximus, Inc. entered into a second amendment to its amended and restated credit agreement, adding US$325,000,000 in Tranche B-1 term loans with JPMorgan Chase Bank and other lenders to repay revolving borrowings, repurchase shares, fund working capital, and cover related fees.
• This refinancing and capital allocation move reshapes Maximus’ balance sheet flexibility and signals management’s willingness to use additional debt to support share repurchases and operations.
• Next, we’ll examine how Maximus’ expanded US$325,000,000 term B borrowing may influence its existing investment narrative and perceived capital discipline.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.

Maximus Investment Narrative Recap

To own Maximus, you need to believe that governments will keep outsourcing complex health and human services work and that Maximus can protect margins while modernizing with AI and digital tools. The new US$325,000,000 Tranche B-1 term loan increases financial leverage but mainly refinances existing borrowings and supports the new buyback program, so it does not appear to change the near term demand catalyst or the core risk of contract and volume volatility in a material way.

The May 2026 expansion of the share repurchase authorization to US$400,000,000 ties directly into this new term loan, since management has explicitly earmarked some proceeds for stock buybacks. That combination of higher debt and accelerated repurchases sits alongside Maximus’ investment in tools like the SNAP focused Accuracy Assistant AI, and together they frame the current debate about how much capital can be returned while still funding the technology needed to support future contract wins and margin resilience.

Yet against that backdrop, the increased reliance on debt funded buybacks raises concentration and refinancing risks that investors should be aware of as they consider whether...

Maximus' narrative projects $5.8 billion revenue and $498.1 million earnings by 2029. This requires 2.8% yearly revenue growth and about a $126 million earnings increase from $371.8 million today.

Uncover how Maximus' forecasts yield a $110.00 fair value, a 81% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts, who were assuming earnings near US$493 million by 2029 and a higher future earnings multiple, see the buyback fueled by this new US$325,000,000 borrowing as a powerful earnings per share lever, whereas more cautious views focus on how added leverage amplifies exposure to contract loss and budget pressures, so you should weigh how far your own expectations sit between these very different possibilities.

Explore 2 other fair value estimates on Maximus - why the stock might be worth over 4x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Maximus research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Maximus research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Maximus' overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.